WHO Classification of of Tumours of the Urinary System and Male Genital Organs
This document is intended to assist in the preparation of future studies on how to integrate Python into the e-commerce system.
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues
- T. Ulbright
- MedicineModern Pathology
- 1 February 2005
As expected, teratomas in boys are clinically benign, whereas in postpubertal males they are malignant, independent of their degree of immaturity, and the judicious use of tailored panels of immunohistochemical stains resolve these dilemmas in virtually all instances.
Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases.
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
Findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches, and at least one germline or somatic deleterious SMarCA4 mutation in 30 of 32 cases.
OCT4 Staining in Testicular Tumors: A Sensitive and Specific Marker for Seminoma and Embryonal Carcinoma
- T. Jones, T. Ulbright, J. Eble, L. Baldridge, Liang Cheng
- MedicineAmerican Journal of Surgical Pathology
- 1 July 2004
It is concluded that immunostaining with antibodies to OCT4 is a useful diagnostic tool in the identification of primary testicular embryonal carcinomas and “usual,” but not spermatocytic, seminomas.
OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis.
OCT4 is a sensitive and specific maker for intratubular germ cell neoplasia, unclassified, and a putative precursor for adult germ cell tumors, according to the results of the present study.
The development of non‐germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases
- T. Ulbright, P. Loehrer, L. Roth, L. Einhorn, S. Williams, Steven A. Clark
- 1 November 1984
It is currently recommended, when feasible, that patients with teratoma and sarcoma undergo total surgical excision, and further treatment with cisplatin regimens, after eradication of the germ cell component, has not been helpful.
Update on late relapse of germ cell tumor: a clinical and molecular analysis.
Analysis of patients with late relapse of germ cell tumor with reports on clinical characteristics, outcomes, and molecular and cytogenetic features concluded that surgical resection alone remains the preferred therapy.